Cargando…

Epitope analysis and protection by a ROP19 DNA vaccine against Toxoplasma gondii

We used bioinformatics approaches to identify B-cell and T-cell epitopes on the ROP19 protein of Toxoplasma gondii. Then, we constructed plasmids with ROP19 (pEGFP-C1-ROP19) and injected them into BALB/c mice to test the immunoprotection induced by this vaccine candidate. The results showed that imm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Jian, Wang, Lin, Lu, Gang, Zhou, Aihua, Zhu, Meiyan, Li, Qihang, Wang, Zhilin, Arken, Miradel, Wang, Ao, He, Shenyi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	EDP Sciences 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4824872/ https://www.ncbi.nlm.nih.gov/pubmed/27055564 http://dx.doi.org/10.1051/parasite/2016017

Ejemplares similares

DNA Vaccines Encoding Toxoplasma gondii Cathepsin C 1 Induce Protection against Toxoplasmosis in Mice
por: Han, Yali, et al.
Publicado: (2017)

Protection via a ROM4 DNA vaccine and peptide against Toxoplasma gondii in BALB/c mice
por: Han, Yali, et al.
Publicado: (2017)

Immune Protection of Rhoptry Protein 21 (ROP21) of Toxoplasma gondii as a DNA Vaccine Against Toxoplasmosis
por: Zhang, Zhenchao, et al.
Publicado: (2018)

Influenza Virus-Like Particles Presenting both Toxoplasma gondii ROP4 and ROP13 Enhance Protection against T. gondii Infection
por: Kang, Hae-Ji, et al.
Publicado: (2019)

Vaccination with toxofilin DNA in combination with an alum-monophosphoryl lipid A mixed adjuvant induces significant protective immunity against Toxoplasma gondii
por: Song, Pengxia, et al.
Publicado: (2017)

Adjuvantic cytokine IL-33 improves the protective immunity of cocktailed DNA vaccine of ROP5 and ROP18 against toxoplasma gondii infection in mice
por: Zhu, Yu-Chao, et al.
Publicado: (2020)

Alpha-galactosylceramide enhances protective immunity induced by DNA vaccine of the SAG5D gene of Toxoplasma gondii
por: Lu, Gang, et al.
Publicado: (2014)

Immunogenicity of a Virus-Like-Particle Vaccine Containing Multiple Antigenic Epitopes of Toxoplasma gondii Against Acute and Chronic Toxoplasmosis in Mice
por: Guo, Jingjing, et al.
Publicado: (2019)

Comparative efficacy of a multi-epitope DNA vaccine via intranasal, peroral, and intramuscular delivery against lethal Toxoplasma gondii infection in mice
por: Cong, Hua, et al.
Publicado: (2014)

Mucosal Administration of Recombinant Baculovirus Displaying Toxoplasma gondii ROP4 Confers Protection Against T. gondii Challenge Infection in Mice
por: Yoon, Keon-Woong, et al.
Publicado: (2021)

Toxoplasma gondii cathepsin proteases are undeveloped prominent vaccine antigens against toxoplasmosis
por: Zhao, Guanghui, et al.
Publicado: (2013)

Expression and Purification of Recombinant ROP1 of Toxoplasma gondii in Bacteria
por: Mohabati, Reyhaneh, et al.
Publicado: (2013)

Screening and Identification of the Host Proteins Interacting with Toxoplasma gondii Rhoptry Protein ROP16
por: Pan, Ming, et al.
Publicado: (2017)

DNA prime and peptide boost immunization protocol encoding the Toxoplasma gondii GRA4 induces strong protective immunity in BALB/c mice
por: Meng, Min, et al.
Publicado: (2013)

The Polymorphic Pseudokinase ROP5 Controls Virulence in Toxoplasma gondii by Regulating the Active Kinase ROP18
por: Behnke, Michael S., et al.
Publicado: (2012)

Protective efficacy of recombinant canine adenovirus type-2 expressing TgROP18 (CAV-2-ROP18) against acute and chronic Toxoplasma gondii infection in mice
por: Li, Xiu-Zhen, et al.
Publicado: (2015)

Orally Administrated Recombinant Vaccinia Virus Displaying ROP4 Induces Protection against Toxoplasma gondii Challenge Infection
por: Yoon, Keon-Woong, et al.
Publicado: (2022)

Identification and characterization of Toxoplasma gondii aspartic protease 1 as a novel vaccine candidate against toxoplasmosis
por: Zhao, Guanghui, et al.
Publicado: (2013)

Analysis of Structures and Epitopes of Surface Antigen Glycoproteins Expressed in Bradyzoites of Toxoplasma gondii
por: Cong, Hua, et al.
Publicado: (2013)

The Rhoptry Proteins ROP18 and ROP5 Mediate Toxoplasma gondii Evasion of the Murine, But Not the Human, Interferon-Gamma Response
por: Niedelman, Wendy, et al.
Publicado: (2012)

Toxoplasma gondii Superinfection and Virulence during Secondary Infection Correlate with the Exact ROP5/ROP18 Allelic Combination
por: Jensen, Kirk D. C., et al.
Publicado: (2015)

ROP18 Is a Rhoptry Kinase Controlling the Intracellular Proliferation of Toxoplasma gondii
por: El Hajj, Hiba, et al.
Publicado: (2007)

Protein targets of thiazolidinone derivatives in Toxoplasma gondii and insights into their binding to ROP18
por: Molina, Diego, et al.
Publicado: (2018)

Toxoplasma gondii ROP16(I) Deletion: The Exacerbated Impact on Adverse Pregnant Outcomes in Mice
por: Cui, Wen, et al.
Publicado: (2020)

Detection of Toxoplasma gondii Infections using Virus-Like Particles Displaying T. gondii ROP4 Antigen
por: Kim, Min-Ju, et al.
Publicado: (2021)

Rhoptry Proteins ROP5 and ROP18 Are Major Murine Virulence Factors in Genetically Divergent South American Strains of Toxoplasma gondii
por: Behnke, Michael S., et al.
Publicado: (2015)

The secreted kinase ROP17 promotes Toxoplasma gondii dissemination by hijacking monocyte tissue migration
por: Drewry, Lisa L, et al.
Publicado: (2019)

Sequence Variation in Toxoplasma gondii rop17 Gene among Strains from Different Hosts and Geographical Locations
por: Zhang, Nian-Zhang, et al.
Publicado: (2014)

A Toxoplasma gondii vaccine encoding multistage antigens in conjunction with ubiquitin confers protective immunity to BALB/c mice against parasite infection
por: Yin, Huiquan, et al.
Publicado: (2015)

The Toxoplasma gondii virulence factor ROP16 acts in cis and trans, and suppresses T cell responses
por: Chen, Longfei, et al.
Publicado: (2020)

Prediction of Toxoplasma gondii virulence factor ROP18 competitive inhibitors by virtual screening
por: Yin, Kun, et al.
Publicado: (2019)

Preparation and Preliminary Application of Epitope Peptide-Based Antibody against Toxoplasma gondii GRA3
por: Wang, Ru, et al.
Publicado: (2023)

Toxoplasma gondii infection in humans in China
por: Zhou, Peng, et al.
Publicado: (2011)

ROP18 Is a Key Factor Responsible for Virulence Difference between Toxoplasma gondii and Neospora caninum
por: Lei, Tao, et al.
Publicado: (2014)

The Toxoplasma gondii protein ROP2 mediates host organelle association with the parasitophorous vacuole membrane
por: Sinai, Anthony P., et al.
Publicado: (2001)

The Rhoptry Pseudokinase ROP54 Modulates Toxoplasma gondii Virulence and Host GBP2 Loading
por: Kim, Elliot W., et al.
Publicado: (2016)

Differential Impacts on Host Transcription by ROP and GRA Effectors from the Intracellular Parasite Toxoplasma gondii
por: Rastogi, Suchita, et al.
Publicado: (2020)

ROP39 is an Irgb10-specific parasite effector that modulates acute Toxoplasma gondii virulence
por: Singh, Shishir, et al.
Publicado: (2023)

Toxoplasma gondii gra5 deletion mutant protects hosts against Toxoplasma gondii infection and breast tumors
por: Chen, Min, et al.
Publicado: (2023)

Immunization with a DNA vaccine encoding Toxoplasma gondii Superoxide dismutase (TgSOD) induces partial immune protection against acute toxoplasmosis in BALB/c mice
por: Liu, Yuan, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_vqub4cbmeancntgmk3gc3h9360